High antagonist potency of GT-2227 and GT-2331, new histamine H3receptor antagonists, in two functional models

  • Tedford C
  • Hoffmann M
  • Seyedi N
 et al. 
  • 5


    Mendeley users who have this article in their library.
  • 38


    Citations of this article.


GT-2227 (4-(6-cyclohexylhex-cis-3-enyl)imidazole) and GT-2331 ((1R,2R)-4-(2-(5,5-dimethylhex-1-ynyl)cyclopropyl)imidazole) were developed as new potent histamine H3receptor antagonists. The functional activity of these ligands on the histamine H3receptor-mediated inhibition of neurogenic contraction of the guinea-pig jejunum and histamine H3receptor-mediated inhibition of norepinephrine release from guinea-pig heart synaptosomes were investigated. GT-2227 and GT-2331 both antagonized the inhibitory effects of (R)-α-methylhistamine on the contraction induced by electrical field stimulation in the guinea-pig jejunum with pA2values of 7.9±0.1 and 8.5±0.03, respectively. In addition, GT-2227 and GT-2331 antagonized the inhibition of norepinephrine release in cardiac synaptosomes by GT-2203 ((1R,2R)-trans-2-(1H-imidazol-4-yl)cyclopropylamine), a histamine H3receptor agonist. The current results demonstrate the antagonist activity for both GT-2227 and GT-2331 in two functional assays for histamine H3receptors. Copyright (C) 1998 Elsevier Science B.V. All rights reserved.

Author-supplied keywords

  • GT-2227
  • GT-2331
  • Heart
  • Histamine H3receptor
  • Jejunum
  • Norepinephrine

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Clark E. Tedford

  • Marcel Hoffmann

  • Nahid Seyedi

  • Ryushi Maruyama

  • Roberto Levi

  • Stephen L. Yates

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free